Please be aware that a company called Neorex Biomedical is impersonating Veriton Pharma and its executives.
Veriton has no association or links with Neorex Biomedical and is taking legal action against this fraudulent company.
If you have been approached by Neorex Biomedical please contact us at legal@serb.eu
  • About Us
    • About Us Overview
    • Company
    • History
    • Leadership Team
    • Testimonials
    • Sponsorship
    • Anti-Bribery Statement
    • Privacy Policy
  • Products
    • Products Overview
    • Licensed Products Overview
    • Epistatus®
    • Licensed Products
      • Epistatus®
    • Unlicensed Products Overview
    • Epilepsy
    • Paediatric Medicine
    • Inborn Errors of Metabolism
    • FAQs
    • Unlicensed Products
      • Epilepsy
      • Paediatric Medicine
      • Inborn Errors of Metabolism
      • FAQs
  • Quality & Service
    • Quality & Service Overview
    • Medical Information & Quality
    • Commercial Team
    • Ordering
  • Distribution
    • Distribution Overview
    • Distribution Footprint
    • Licensing Opportunities
    • Out-licensing Opportunities
  • Careers
  • News & Events
  • Contact Us

History

In October 2017, Special Products Limited changed its company name to Veriton Pharma. This name change has occurred to incorporate our past heritage with our future ambitions ensuring our products continue to make a real difference to people’s lives.

The company was founded in 1997 by Dr Graham March, a pharmacist with substantial experience of the formulation of medicines gained whilst working at major pharmaceutical companies and within the UK’s National Health Service.

The team of formulation experts at Veriton Pharma has since developed more than 60 “specials” for a targeted range of therapeutic areas. The company has grown rapidly, supplying products to more than 25 countries.

In May 2020 Veriton Pharma were acquired by SERB Pharmaceuticals, a leading European specialty pharmaceutical group focused on prescription medicines that address rare and life-threatening diseases. SERB’s focus on critical care and answering unmet needs is closely aligned with Veriton’s history and approach, and as part of an integrated group they can take their growth to the next level.

Unlicensed 'Special' Products

Our heritage of developing tailor-made medications enables Veriton Pharma to provide a range of unlicensed therapy options for those patients whose clinical needs are not met by licensed medications.

Find out more

What people say

“We have ordered certain medicines from Veriton Pharma  for many years and find that you are always there when we need you, a friendly contact...”- Procurement Pharmacist; NHS hospital
“Thank you for putting together a superb educational day for myself and the other epilepsy nurses. We all learned so much that will help patients...”- Sarah. Epilepsy Specialist Nurse, NHS Wales
“Veriton Pharma truly went that extra mile to ensure a patients emergency medication was supplied at short notice enabling the patient to travel outside the...”- Epilepsy Nurse Specialist, Glasgow
“Just to say a big thank you for your support with training materials. It was great to have someone on my side trying to sort...”- Clinical Nurse Specialist/Training Lead
More testimonials

News

    • SERB Announces the Acquisition of Veriton Pharma

                                                                 … Read More

    • SAPHNA Annual Conference 2019: HEALTH FOR ALL CHILDREN

      SAPHNA Annual Conference 2019: 18th June in Manchester We are delighted to be attending the upcoming SAPHNA Annual Conference; HEALTH FOR ALL CHILDREN – School and Public Health Nurses Turning the Tide…. Read More

    • Young Epilepsy online guide for school

      Veriton Pharma is pleased to announce the online publication of the charity Young Epilepsy’s online guide for schools. This comprehensive resource aimed at improving the management and support of children with epilepsy… Read More

    • Young Epilepsy and Veriton Pharma Ltd announce key partnership agreement in support of the charity’s ‘Rules 4 Schools’ campaign

      Young Epilepsy and Veriton Pharma Ltd (Veriton) have announced a key agreement, where the organisations will work in partnership to deliver the ‘Rules 4 Schools” element of the charity’s newly… Read More

About us
  • Careers
  • Privacy policy
  • Company
  • History
  • Leadership Team
  • Testimonials
  • Sponsorship
  • Anti-Bribery Statement
Licensed Products
  • Epistatus®
Unlicensed Products
  • Epilepsy
  • Paediatric Medicine
  • Inborn Errors of Metabolism
  • FAQs
Quality & Service
  • Medical Information & Quality
  • Commercial Team
  • Ordering
Distribution
  • Distribution Footprint
  • Licensing Opportunities
  • Out-licensing Opportunities
© 2017 VERITON PHARMA | Privacy policy | Terms and conditions | another immaculate site
Contact us Linkedin